Ang II, aldosterone, and TGF-β1 can promote the transformation and proliferation of myofibroblasts, which are therapeutic targets for the treatment of myocardial fibrosis (Shinde and Frangogiannis, 2014). This evidence concerns the gene TGFB1 and Myocardial fibrosis.